Skip to content

Janus Living

US · JAN #1620 by market cap Listed 2026
27.83 -0.73 -2.56%
Live - 5344 symbols - heartbeat 535s ago · 2026-10-07 19:54
After-hours 27.83 0.00%
Market cap
6.52B
P/B
2.38
EPS
-0.34
Reader sentiment Are you bullish or bearish on JAN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership fell 7.2 percentage points.

Institutional ownership

Held by institutions
97.38% -7.22pp
Institutions
211 +4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

REIT61.78%
Mutual Fund24.40%
Hedge Fund9.26%
Insurance Company0.44%
Private Company0.40%
Public Company0.26%
Family Office/Trust0.23%
Sovereign Wealth Fund0.22%
VC/PE Fund0.22%
Other2.80%

Top holders as of 2026-08-10

Healthpeak Properties, Inc. 59.84% · 138.82M sh
BlackRock 3.70% · 8.59M sh
MFS Investment Management 2.02% · 4.69M sh
PGIM, Inc. 1.63% · 3.79M sh
Vanguard Capital Management, LLC 1.54% · 3.58M sh
RREEF America L.L.C. 1.44% · 3.34M sh
Millennium Management LLC 1.41% · 3.27M sh
Alyeska Investment Group, L.P. 1.16% · 2.68M sh
Principal Global Investors, LLC 1.15% · 2.66M sh
Vanguard Portfolio Management, LLC 1.14% · 2.65M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

24 filings tracked · 21 buys · 0 sells

NameRoleStake
Healthpeak Properties, Inc. -- 59.84%
Scott Brinker Chief Executive Officer 0.04%
John Arabia Lead Independent Director 0.03%
Katherine Sandstrom Independent Director 0.01%
Kelvin Moses Chief Financial Officer 0.01%
Adam Mabry Chief Investment Officer 0.01%
Charles Herman Independent Director 0.01%
Shawn Johnston Chief Accounting Officer 0.00%
Ankit Patadia Executive VP of Corporate Finance, Treasurer and Head of Finance & Capital Markets 0.00%
Tracy Porter Executive VP, General Counsel & Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-03-22 Charles Herman Independent Director Other Acquisition +2,500 --
2026-03-22 Charles Herman Independent Director Other Acquisition +5,000 --
2026-03-22 Charles Herman Independent Director Private Acquisition +5,500 $20.00
2026-03-22 Jeffrey Miller Chief Operating Officer Private Acquisition +7,500 $20.00
2026-03-22 Jeffrey Miller Chief Operating Officer Other Derivative Acquisition +12,500 --
2026-03-22 John Arabia Lead Independent Director Other Acquisition +2,500 --
2026-03-22 John Arabia Lead Independent Director Other Acquisition +5,000 --
2026-03-22 John Arabia Lead Independent Director Private Acquisition +60,000 $20.00
2026-03-22 Denise Olsen Independent Director Other Acquisition +2,500 --
2026-03-22 Denise Olsen Independent Director Other Acquisition +5,000 --
2026-03-22 Denise Olsen Independent Director Private Acquisition +500 $20.00
2026-03-22 Katherine Sandstrom Independent Director Other Acquisition +2,500 --
2026-03-22 Katherine Sandstrom Independent Director Other Acquisition +5,000 --
2026-03-22 Katherine Sandstrom Independent Director Private Acquisition +13,500 $20.00
2026-03-22 Scott Brinker Chief Executive Officer Private Acquisition +100,000 $20.00
2026-03-22 Scott Brinker Chief Executive Officer Other Derivative Acquisition +25,000 --
2026-03-22 Shawn Johnston Chief Accounting Officer Other Derivative Acquisition +10,000 --
2026-03-22 Adam Mabry Chief Investment Officer Other Derivative Acquisition +15,000 --
2026-03-22 Ankit Patadia Executive VP of Corporate Finance, Treasurer and Head of Finance & Capital Markets Other Derivative Acquisition +10,000 --
2026-03-22 Tracy Porter Executive VP, General Counsel & Director Other Derivative Acquisition +10,000 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.